Tinzaparin in cancer associated thrombosis beyond 6months: TiCAT study.
Sign Up to like & getrecommendations! Published in 2017 at "Thrombosis research"
DOI: 10.1016/j.thromres.2017.07.004
Abstract: INTRODUCTION The safety and efficacy of low-molecular-weight heparin (LMWH) treatment in patients with cancer-associated thrombosis (CAT) beyond 6months are unknown. Our aim was to determine the safety of long-term tinzaparin use in patients with CAT.… read more here.
Keywords: tinzaparin; beyond 6months; clinically relevant; cancer associated ... See more keywords
Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial.
Sign Up to like & getrecommendations! Published in 2018 at "Thrombosis research"
DOI: 10.1016/j.thromres.2018.08.006
Abstract: OBJECTIVE Foetal growth retardation (FGR) is a leading cause of perinatal death and long-term harms at survivors. Placental infarction plays a role in FGR, yet, no trials have evaluated whether low molecular weight heparins increase… read more here.
Keywords: tinzaparin; foetal growth; trial; treatment ... See more keywords
Safety and Efficacy of Tinzaparin Anticoagulation during Nocturnal Hemodialysis
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Nephrology"
DOI: 10.1159/000502506
Abstract: Background: The safety and efficacy of low-molecular-weight heparin in the prevention of extracorporeal dialysis circuit clotting among in-center extended duration nocturnal hemodialysis (INHD) patients are unknown. The aim of this study was to determine the… read more here.
Keywords: tinzaparin; hemodialysis; safety efficacy; inhd ... See more keywords
Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2018 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/1076029617696581
Abstract: Patients with cancer are at increased risk of recurrent venous thromboembolism (VTE) and bleeding. Thus, long-term treatment with anticoagulants for secondary prevention is challenging. The objective of this review was to evaluate current evidence on… read more here.
Keywords: tinzaparin; long term; treatment; patients cancer ... See more keywords
Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/1076029620979592
Abstract: Low-molecular-weight heparins are approved for primary and secondary venous thromboembolism prevention. Tinzaparin is the low-molecular-weight heparin with the highest average molecular weight. The purpose of this systematic review is to provide an update regarding the… read more here.
Keywords: tinzaparin; safety; patients renal; renal impairment ... See more keywords
The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13122884
Abstract: Simple Summary Pancreatic cancer (PaC) induces a prothrombotic and hypercoagulable state. Thrombosis occurs in 20% of PaC patients and is associated with worse prognosis and reduced progression-free survival (PFS). The aim of this retrospective observational… read more here.
Keywords: tinzaparin; pfs; pfs patients; study ... See more keywords